Aurinia Pharmaceuticals (AUPH) P/E (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM Aurinia Pharmaceuticals (AUPH) P/E is 9.31. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Aurinia Pharmaceuticals (AUPH)
| Year | P/E | Change |
|---|---|---|
| 2026 | 9.31 | -7.39% |
| 2025 | 10.05 | -98.88% |
| 2024 | 899.67 | +272.32% |
| 2023 | 241.64 | +1177.24% |
| 2022 | 18.92 | -128.11% |
| 2021 | -67.30 | +213.26% |
| 2020 | -21.48 | N/A |
Comparison Aurinia Pharmaceuticals (AUPH) P/E with competitors
Aurinia Pharmaceuticals (AUPH) P/E is 9.31.